Removal of toxic metal Cd (II) by Serratia bozhouensis CdIW2 using in moving bed biofilm reactor (MBBR).


Journal

Journal of environmental management
ISSN: 1095-8630
Titre abrégé: J Environ Manage
Pays: England
ID NLM: 0401664

Informations de publication

Date de publication:
15 Oct 2023
Historique:
received: 02 02 2023
revised: 04 06 2023
accepted: 07 06 2023
medline: 18 9 2023
pubmed: 23 6 2023
entrez: 22 6 2023
Statut: ppublish

Résumé

The use of bioreactor technology to treat industrial wastewater containing heavy metals has created new perspectives. Cadmium metal is one of the toxic heavy metals that have harmful effects on human health and the environment. This research work presents a comprehensive approach for aqueous cadmium removal through biosorption in a moving bed biofilm reactor (MBBR). The bacterium resistant to Cd(II) (350 mg/L) CdIW2 was selected among 8 cadmium tolerant bacteria isolated from the industrial wastewater of the metal industry. 16S rRNA gene and phenotypic analysis showed that the bacterium CdIW2 is similar to Serratia bozhouensis. The highest biosorption capacity of 65.79 mg/g was acquired in optimal conditions (30 min, pH = 6, 0.5 g/L, and 35 °C). The biosorption of the CdIW2 strain was consistent with the Langmuir isotherm and the pseudo-second order kinetic and showed the process's spontaneous thermodynamic and endothermic results. The removal rate 91.74% of MBBR in batch mode was obtained in 72 h and 10 mg/L of Cd(II). Furthermore, continuous mode bioreactor analysis has shown high efficiency at intel loading rates of 6-36 mg/L. day for cadmium removal. The second order kinetic (Grau) was chosen as the suitable model for modeling the MBBR process. Although several studies have evaluated the removal of various types of heavy metals, none of the studies involved the use of a metal-resistant strain in an MBBR bioreactor.

Identifiants

pubmed: 37348303
pii: S0301-4797(23)01149-0
doi: 10.1016/j.jenvman.2023.118361
pii:
doi:

Substances chimiques

Cadmium 00BH33GNGH
Wastewater 0
RNA, Ribosomal, 16S 0
Metals, Heavy 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

118361

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Ahmad Rezaee (A)

Department of Microbiology, Faculty of Science, University of Mazandaran, Babolsar, Iran. Electronic address: a.rezaee@stu.umz.ac.ir.

Salman Ahmady-Asbchin (S)

Department of Microbiology, Faculty of Science, University of Mazandaran, Babolsar, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH